TTM
MCID: TRC010
MIFTS: 40

Trichotillomania (TTM) malady

Categories: Genetic diseases, Rare diseases, Mental diseases

Aliases & Classifications for Trichotillomania

About this section

Aliases & Descriptions for Trichotillomania:

Name: Trichotillomania 52 11 48 70 27 12 39 13 68
Hair-Pulling Syndrome 48
 
Ttm 70

Characteristics:

HPO:

64

Classifications:



External Ids:

OMIM52 613229
Disease Ontology11 DOID:0050587
MeSH39 D014256
ICD1030 F63.3

Summaries for Trichotillomania

About this section
NIH Rare Diseases:48 Trichotillomania is a disorder characterized by an overwhelming urge to repeatedly pull out one's own hair, resulting in hair loss (alopecia).  it is classified under the obsessive-compulsive and related disorders category. trichotillomania results in highly variable patterns of hair loss. the scalp is the most common area of hair pulling, followed by the eyebrows, eyelashes, pubic and perirectal areas, axillae, limbs, torso, and face. the resulting alopecia can range from thin unnoticeable areas of hair loss to total baldness. some people chew or swallow the hair they pull out (trichophagy), which can result in gastrointestinal problems or develop a trichobezoar (hairball in the intestines or stomach). in many cases, people with this disorder feel extreme tension when they feel an impulse, followed by relief, gratification or pleasure afterwards. the disorder may be mild and manageable, or severe and debilitating.  the cause is unknown, though both environmental and genetic causes have been suspected. treatment may involve cognitive behavior therapy, such as habit reversal training (learning to substitute the hair-pulling behavior) and/or drug therapy, but these are not always effective. last updated: 2/24/2017

MalaCards based summary: Trichotillomania, also known as hair-pulling syndrome, is related to obsessive-compulsive disorder and alopecia, and has symptoms including obsessive-compulsive behavior, alopecia and hair-pulling. An important gene associated with Trichotillomania is SLITRK1 (SLIT And NTRK Like Family Member 1). Affiliated tissues include eye, skin and brain.

UniProtKB/Swiss-Prot:70 Trichotillomania: A neuropsychiatric disorder characterized by chronic, repetitive, or compulsive hair pulling resulting in noticeable hair loss. Affected individuals may develop physical complications and often have overlapping psychological disorders, such as Gilles de la Tourette syndrome or obsessive-compulsive disorder.

OMIM:52 Trichotillomania (TTM) is a neuropsychiatric disorder characterized by chronic, repetitive, or compulsive hair pulling... (613229) more...

Disease Ontology:11 An impulse control disorder that involves the uncontrollable plucking of ones hair.

Wikipedia:71 Trichotillomania (TTM), also known as hair pulling disorder, is an impulse control disorder... more...

Related Diseases for Trichotillomania

About this section

Graphical network of the top 20 diseases related to Trichotillomania:



Diseases related to trichotillomania

Symptoms & Phenotypes for Trichotillomania

About this section

Symptoms by clinical synopsis from OMIM:

613229

Clinical features from OMIM:

613229

Human phenotypes related to Trichotillomania:

 64
id Description HPO Frequency HPO Source Accession
1 obsessive-compulsive behavior64 HP:0000722
2 alopecia64 HP:0001596
3 hair-pulling64 HP:0012167

Drugs & Therapeutics for Trichotillomania

About this section

Drugs for Trichotillomania (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 71)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Methylphenidateapproved, investigationalPhase 4375113-45-14158
Synonyms:
.alpha.-Phenyl-2-piperidineacetic acid methyl ester
113-45-1
2-Piperidineacetic acid, .alpha.-phenyl-, methyl ester
2-Piperidineacetic acid, alpha-phenyl-, methyl ester
298-59-9 (hydrochloride)
4311/B Ciba
AC1L1HJM
C 4311
C07196
CHEBI:6887
CHEMBL796
CID4158
Calocain
Centedein
Centedrin
Centedrine
Centredin
Concerta
D-Methylphenidate HCl
D04999
DB00422
DB06701
DEA No. 1724
Daytrana
Daytrana (TN)
EINECS 204-028-6
Focalin
Focalin XR
HSDB 3126
L001307
LS-565
METHYLPHENIDATE (SEE ALSO: METHYLPHENIDATE HYDROCHLORIDE, CAS 298-59-9, NTPNO 10266-R)
MPH
Meridil
Metadate
Metadate CD
Metadate ER
MethyPatch
Methyl (2-phenyl-2-(2-piperidyl)acetate)
Methyl alpha-phenyl-alpha-(2-piperidyl)acetate
Methyl alpha-phenyl-alpha-2-piperidinylacetate
Methyl phenidate
 
Methyl phenidyl acetate
Methyl phenidylacetate
Methylfenidan
Methylin
Methylin ER
Methylofenidan
Methylphen
Methylphenidan
Methylphenidate
Methylphenidate (USAN/INN)
Methylphenidate HCl
Methylphenidate [INN:BAN]
Methylphenidate hydrochloride
Methylphenidatum
Methylphenidatum [INN-Latin]
Methylphenidylacetate hydrochloride
Methypatch
Metilfenidat hydrochloride
Metilfenidato
Metilfenidato [INN-Spanish]
Metilfenidato [Italian]
MolPort-001-779-620
NCI-C56280
PMS-Methylphenidate
Phenidylate
Plimasine
Riphenidate
Ritalin
Ritalin LA
Ritalin SR
Ritalin hydrochloride
Ritalin-SR
Ritaline
Ritcher Works
Ritcher works
Tsentedrin
UNII-207ZZ9QZ49
alpha-Phenyl-2-piperidineacetic acid methyl ester
alpha-Phenyl-alpha-(2-piperidyl)acetic acid methyl ester
d-methylphenidate HCl
methyl 2-phenyl-2-piperidin-2-ylacetate
methyl phenyl(piperidin-2-yl)acetate
methylphenidate
nchembio.2007.55-comp28
2
DopamineapprovedPhase 4383651-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
3
SertralineapprovedPhase 429979617-96-268617
Synonyms:
(+)-Sertraline
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine
(1S,4S)-sertraline
(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
(1S-cis)-1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
(1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine
79559-97-0 (Hydrochloride)
79617-96-2
AB00514002
AB1004870
AC-15639
AC1L2A41
AC1Q3O5N
AC1Q3XJU
Apo-Sertraline
BIDD:GT0768
BIDD:PXR0193
BPBio1_001285
BRD-K82036761-003-02-1
BRN 5753709
BSPBio_001167
BSPBio_002698
C07246
C17H17Cl2N
CHEBI:9123
CHEMBL809
CID68617
Cp 51974
D02360
DB01104
DB08567
FT-0081122
HSDB 7037
KBio3_001918
 
KBioGR_001724
LS-94179
Lustral
MLS001195647
MLS002222308
MolPort-002-885-860
NCGC00092386-03
NCGC00092386-04
NCGC00092386-05
NCGC00092386-06
NCGC00092386-07
NCGC00092386-08
NCGC00092386-09
Prestwick3_001014
SMR000596516
SPBio_000385
SRE
Sertralina
Sertralina [Spanish]
Sertraline
Sertraline (INN)
Sertraline Hydrochloride
Sertraline [INN:BAN]
Sertraline [Zoloft]
Sertraline hydrochloride
Sertralinum
Sertralinum [Latin]
Spectrum2_000493
Spectrum3_001079
Spectrum4_001232
Sultamicillin Tosylate
UNII-QUC7NX6WMB
Zoloft
cis-(+)-sertraline
sertraline
sertraline (Zoloft)
4
Olanzapineapproved, investigationalPhase 4399132539-06-14585
Synonyms:
132539-06-1
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methyl-1-piperazinyl)-10 H -thieno[2,3- b ] [1,5]benzodiazepine
2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine
AC-665
AC1L1IHS
AKOS000282888
ALKS-7921
BIDD:GT0332
BIDD:PXR0138
Bio-0169
C07322
C076029
C17H20N4S
CHEBI:7735
CHEMBL715
CID4585
CPD000466345
D00454
DB00334
Eli Lilly brand of olanzapine
HMS2051H05
HMS2089M04
HMS2093I04
I06-0784
InChI=1/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H
InChI=1/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3
Jsp001969
KS-1090
L000455
L005958
LS-152313
LY 170053
LY-170052
 
LY-170053
Lanzac
Lilly brand of olanzapine
MLS000759457
MLS001165781
MLS001195646
MLS001424057
Midax
MolPort-002-885-845
MolPort-003-666-569
MolPort-005-977-341
NCGC00096077-01
NCGC00096077-03
NCGC00096077-04
Olansek
Olanzapin
Olanzapina
Olanzapine
Olanzapine (JAN/USAN/INN)
Olanzapine (OLA)
Olanzapine [USAN:INN]
Olanzapinum
S2493_Selleck
SAM001246652
SMR000466345
SPECTRUM1505024
STK634338
Symbyax
TL8000772
UNII-N7U69T4SZR
Zalasta
Zydis
Zyprexa
Zyprexa (TN)
Zyprexa Intramuscular
Zyprexa Velotab
Zyprexa Zydis
olanzapina
olanzapine
olanzapinum
5Central Nervous System StimulantsPhase 42211
6Neurotransmitter Uptake InhibitorsPhase 43521
7Dopamine AgentsPhase 43836
8Dopamine Uptake InhibitorsPhase 41331
9Neurotransmitter AgentsPhase 4, Phase 218340
10
SerotoninPhase 4362750-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
11Serotonin AgentsPhase 43156
12Tranquilizing AgentsPhase 44265
13Psychotropic DrugsPhase 4, Phase 26430
14Serotonin Uptake InhibitorsPhase 41587
15Antidepressive AgentsPhase 4, Phase 22736
16Antipsychotic AgentsPhase 42401
17Peripheral Nervous System AgentsPhase 4, Phase 223689
18AntiemeticsPhase 44022
19Autonomic AgentsPhase 410150
20Gastrointestinal AgentsPhase 48402
21Central Nervous System DepressantsPhase 4, Phase 213403
22
Dronabinolapproved, illicitPhase 21441972-08-316078, 2978
Synonyms:
&Delta
(-)- delta 9-Tetrahydrocannabinol
(-)-.DELTA.1-Tetrahydrocannabinol
(-)-.DELTA.9-THC
(-)-.DELTA.9-Tetrahydrocannabinol
(-)-.DELTA.9-trans-Tetrahydrocannabinol
(-)-.delta.(sup9)-trans-Tetrahydrocannabinol
(-)-3,4-trans-Delta1-Tetrahydrocannabinol
(-)-delta (sup9)-trans-Tetrahydrocannabinol
(-)-delta 1-Tetrahydrocannabinol
(-)-delta 9-THC
(-)-delta 9-trans-Tetrahydrocannabinol
(-)-delta(sup 1)-3,4-trans-Tetrahydrocannabinol
(-)-delta1-Tetrahydrocannabinol
(-)-delta9-(trans)-Tetrahydrocannabinol
(-)-delta9-Tetrahydrocannabinol
(-)-delta9-trans-Tetrahydrocannabinol
(-)-trans-.DELTA.9-Tetrahydrocannabinol
(-)-trans-Delta1-Tetrahydrocannabinol
(-)-trans-Delta9-THC
(-)-trans-delta 1-Tetrahydrocannabinol
(-)-trans-delta 9-THC
(-)-trans-delta 9-Tetrahydrocannabinol
(-)-trans-delta9-Tetrahydrocannabinol
(L)-.delta.1-Tetrahydrocannabinol
(L)-delta 1-Tetrahydrocannabinol
(l)-delta(sup 1)-Tetrahydrocannabinol
(l)-delta1-Tetrahydrocannabinol
.DELTA.1-THC
.DELTA.1-Tetrahydrocannabinol
.DELTA.9-THC
.DELTA.9-trans-Tetrahydrocannabinol
.delta.(sup9)-THC
.delta.-9-THC
1-trans-.delta.(sup9)-tetrahydrocannabinol
1-trans-D9-Tetrahydrocannabinol
1-trans-delta (sup9)-tetrahydrocannabinol
1-trans-delta 9-Tetrahydrocannabinol
1-trans-delta(sup 9)-Tetrahydrocannabinol
1-trans-delta(sup9)-tetrahydrocannabinol
1-trans-delta-9-Tetrahydrocannabinol
1-trans-delta9-Tetrahydrocannabinol
1363-19-5
14146-29-3
14146-43-1
14C-.DELTA.1-Tetrahydrocannabinol
14C-delta 1-Tetrahydrocannabinol
1972-08-3
26108-45-2
3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,D)pyran-1-ol
308064-99-5
5957-27-7
6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol
6465-30-1
6H-Dibenzo
9-THC
9-delta-Tetrahydrocannabinol
9-ene-Tetrahydrocannabinol
9-tetrahydrocannabinol
AC1L277U
AC1Q2VRZ
Abbott 40566
BIDD:GT0427
C06972
CAT-310
CCRIS 4726
CHEBI:104496
CHEMBL465
CID16078
Cannabinol, Delta1-tetrahydro- (7CI)
Cannabinol, tetrahydro- (6CI)
Cannabis resin
Compassia
D00306
DB00470
DEA No. 7369
DEA No. 7370
DRG-0138
Dea No. 7369
Dea No. 7370
Delta9-Tetrahydrocannabinol solution
Deltanyne
Drona binol
Dronabinol
Dronabinol (USP/INN)
Dronabinol [USAN:INN]
 
Dronabinol [Usan:Inn]
Dronabinolum
Dronabinolum [Latin]
EPA 28
EPA-PLUS
Exocyclic delta (9)(11)-Tetrahydrocannabiol
Fats and Glyceridic oils, fish, n-3 fatty acid-high
Fish oils, n-3 fatty acid-high
Fish oils, omega-3 fatty acid-high
Ganja
HSDB 6471
Hashish
L-.delta.1-Tetrahydrocannabinol
L-.delta.1-trans-Tetrahydrocannabinol
L-delta 1-trans-Tetrahydrocannabinol
L-delta(sup 1)-tetrahydrocannabinol
L-delta1-trans-Tetrahydrocannabinol
L-trans-.delta.9-Tetrahydrocannabinol
L-trans-delta 9-Tetrahydrocannabinol
L-trans-delta9-Tetrahydrocannabinol
LS-975
Marincap
Marinol
Marinol (TN)
MaxEPA
MolPort-003-959-698
NSC 134454
NSC134454
Namisol
Omegaven
PDSP2_000714
Primolut
Pro-Mega
Promega
QCD 84924
QCD-84924
Relivar
SP 104
Sonergx
T2386_SIGMA
T4764_FLUKA
T4764_SIGMA
TETRAHYDROCANNABINOL
THC
THC-delta-9
Tetrahydrocannabinol
Tetrahydrocannabinol delta9
Tetrahydrocannabinols (-)-delta1-3,4-trans-form
Tetranabinex
UNII-7J8897W37S
ZINC01530625
delta (sup9)-Thc
delta 1-THC
delta 1-Tetrahydrocannabinol
delta 9-THC
delta 9-Tetrahydrocannabinol
delta 9-trans-Tetrahydrocannabinol
delta(1)-THC
delta(1)-Tetrahydrocannabinol
delta(9)-THC
delta(9)-Tetrahydrocannabinol
delta(9)-Tetrahydrocannibinol
delta(sup 1)-Tetrahydrocannabinol
delta(sup 1)-Thc
delta(sup 9)-Tetrahydrocannabinol
delta(sup 9)-Thc
delta-9-THC
delta-9-Tetrahydrocannabinol
delta-9-tetrahydrocannabinol
delta-THC
delta1-THC
delta1-Tetrahydrocannabinol
delta1-Tetrahydrocannabinol (VAN)
delta9-THC
delta9-Tetrahydrocannabinol
delta9-Tetrahydrocannabinol (VAN)
delta9-trans-Tetrahydrocannabinol
nchembio.129-comp1
nchembio.552-comp1
nchembio.86-comp3
omega-3-Fatty acid
trans-.DELTA.9-Tetrahydrocannabinol
trans-delta (-)-9-Tetrahydrocannabinol
trans-delta 9-Tetrahydrocannabinol
trans-delta-9-Tetrahydrocannabinol
trans-delta9-Tetrahydrocannabinol
trans-tetrahydrocannabinol
Δ9-tetrahydrocannabinol
23
Ketamineapproved, vet_approvedPhase 25696740-88-13821
Synonyms:
(+-)-Ketamine
(+/-)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
(+/-)-2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone
(+/-)-Ketamine
(-)-Ketamine
(S)-(-)-Ketamine
(S)-Ketamine
(±)-ketamine
100477-72-3
2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone
2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one
2-(Methylamino)-2-(2-chlorophenyl)cyclohexanone
2-(methylamino)-2-(2-chlorophenyl)cyclohexanone
2-(o-Chlorophenyl)-2-(methylamino)-cyclohexanone
2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone
2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone
33643-45-7
6740-88-1
79499-51-7
AC1L1GSH
AC1Q40UR
AKOS001053247
BRN 2216965
C07525
C13H16ClNO
CHEBI:138833
CHEBI:6121
CHEMBL742
CI 581 base
CI-581
CID3821
CLSTA 20
Calypsol
Cetamina
Cetamina [INN-Spanish]
Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)- (9CI)
Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (+-)- (9CI)
Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (+/-)- (8CI)
D08098
DB01221
 
DEA No. 7285
DL-ketamine
DivK1c_000217
EINECS 229-804-1
Esketamine
Green
IDI1_000217
KBio1_000217
KETAMINE HCL
Ketaject
Ketalar
Ketalar base
Ketamina
Ketamine (INN)
Ketamine Base
Ketamine HCL
Ketamine [INN:BAN]
Ketaminum
Ketaminum [INN-Latin]
Ketanest
Ketoject
Ketolar
Kétamine
L-Ketamine
LS-57301
MLS001331674
MolPort-001-838-070
NCGC00159480-02
NCGC00159480-03
NINDS_000217
NMDA
NSC 70151
NSC70151
SMR000238141
Special K
Special K [street name]
T385
Tekam
Tekam (TN)
UNII-690G0D6V8H
dl-Ketamine
ketamine
l-Ketamine
24
Naltrexoneapproved, investigational, vet_approvedPhase 238816590-41-35360515
Synonyms:
16590-41-3
16676-29-2
17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one
17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one
17-(Cyclopropylmethyl)-4,5α-epoxy-3,14-dihydroxymorphinan-6-one
3,14-dihydroxy-17-(cyclopropylmethyl)-4,5alpha-epoxymorphinan-6-one
BIDD:GT0405
BPBio1_000146
BRD-K88172511-310-03-8
BRN 3596648
BSPBio_000132
C07253
CCRIS 3506
CHEBI:121459
CHEBI:7465
CHEMBL142
CID5360515
Celupan
D05113
DB00704
Depade
EINECS 240-649-9
EN-1639A
HMS2089O11
HS-0002
HSDB 6750
LS-92094
MLS002153483
MolPort-004-920-221
 
MorViva
N-Cyclopropylmethyl-14-hydroxydihydromorphinone
N-Cyclopropylmethylnoroxymorphone
Naltrexon
Naltrexona
Naltrexona [INN-Spanish]
Naltrexone
Naltrexone (USAN/INN)
Naltrexone Hcl
Naltrexone [USAN:BAN:INN]
Naltrexone [USAN:INN:BAN]
Naltrexone [Usan:Ban:Inn]
Naltrexonum
Naltrexonum [INN-Latin]
PDSP2_000847
PTI-555
Prestwick0_000116
Prestwick1_000116
Prestwick2_000116
Prestwick3_000116
ReVia
SMP1_000206
SPBio_002071
UM-792
UNII-5S6W795CQM
Vivitrex
Vivitrol
Vivitrol (TN)
naltrexone
naltrexone (ReVia)
25
Acetylcysteineapproved, investigationalPhase 2330616-91-112035
Synonyms:
(2R)-2-acetylamino-3-sulfanylpropanoic acid
(R)-2-acetylamino-3-mercaptopropanoic acid
(R)-mercapturic acid
2-Acetylamino-3-mercapto-propionate
2-Acetylamino-3-mercapto-propionic acid
ACC
Acetadote
Acetilcisteina
Acetylcysteine
Acetylcysteinum
Fluimicil Infantil
Fluimucetin
Fluimucil
Flumucetin
Fluprowit
 
L-Acetylcysteine
L-acetylcysteine
L-α-acetamido-β-mercaptopropionic acid
Lysox
Mercapturic acid
Mucolysin
Mucomyst
N-Acety-L-Cysteine
N-Acetyl-3-mercaptoalanine
N-Acetyl-L-(+)-cysteine
N-Acetylcysteine
N-acetyl-L-(+)-cysteine
N-acetyl-L-cysteine
N-acetylcysteine
NAC
Parvolex
Sodium 2-acetamido-3-mercaptopropionate
26
Folic Acidapproved, nutraceutical, vet_approvedPhase 2439259-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
27Hormone AntagonistsPhase 213180
28HallucinogensPhase 2179
29Cannabinoid Receptor AgonistsPhase 2125
30Analgesics, Non-NarcoticPhase 26501
31AnalgesicsPhase 211733
32Anesthetics, GeneralPhase 22934
33Excitatory Amino Acid AntagonistsPhase 21347
34Excitatory Amino AcidsPhase 21362
35Respiratory System AgentsPhase 24997
36Anesthetics, IntravenousPhase 22538
37Anesthetics, DissociativePhase 2544
38Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 213168
39AnestheticsPhase 29596
40HormonesPhase 214415
41AntioxidantsPhase 23050
42Protective AgentsPhase 27443
43VitaminsPhase 25282
44Vitamin B ComplexPhase 24337
45Trace ElementsPhase 26001
46MicronutrientsPhase 26001
47AntidotesPhase 21071
48Anti-Infective AgentsPhase 222062
49N-monoacetylcystinePhase 2330
50Narcotic AntagonistsPhase 2935

Interventional clinical trials:

(show all 36)
idNameStatusNCT IDPhase
1Methylphenidate in ADHD With TrichotillomaniaUnknown statusNCT00552266Phase 4
2Olanzapine in the Treatment of Hair Pulling (Trichotillomania)CompletedNCT00182507Phase 4
3Sertraline and Habit Reversal in the Treatment of Patients With TrichotillomaniaCompletedNCT00118014Phase 4
4Testing a New Therapy for TrichotillomaniaUnknown statusNCT00872742Phase 2
5Awareness Enhancement and Monitoring Device for Treatment of TrichotillomaniaCompletedNCT01654523Phase 2
6Naltrexone in the Treatment of TrichotillomaniaCompletedNCT00775229Phase 2
7Inositol in TrichotillomaniaCompletedNCT01875445Phase 2
8N-Acetyl Cysteine in TrichotillomaniaCompletedNCT00354770Phase 2
9N-Acetylcysteine for Pediatric TrichotillomaniaCompletedNCT00993265Phase 2
10Trichotillomania: Group Cognitive-Behavioral TherapyCompletedNCT01968343Phase 2
11Cognitive Behavioral Therapy for TrichotillomaniaCompletedNCT00740909Phase 1, Phase 2
12Stepped Care in the Treatment of TrichotillomaniaCompletedNCT01118637Phase 2
13Marinol in Trichotillomania or Obsessive Compulsive DisorderCompletedNCT01093976Phase 2
14N-acetylcysteine (NAC) for Children With Tourette SyndromeCompletedNCT01172288Phase 2
15Ketamine Infusion for Obsessive-Compulsive DisorderCompletedNCT01349231Phase 2
16Milk Thistle in Trichotillomania in Children and AdultsRecruitingNCT02473913Phase 2
17N-acetylcysteine (NAC) for Pediatric Obsessive-Compulsive DisorderActive, not recruitingNCT01172275Phase 2
18Trial of Aripiprazole in TrichotillomaniaCompletedNCT00947154
19Habit Reversal Training for Children and Adolescents With TrichotillomaniaCompletedNCT01445444
20Online Treatment of TrichotillomaniaCompletedNCT02044237
21Efficacy of COMB (Comprehensive Behavioral) Model of Treatment of TrichotillomaniaCompletedNCT01878110
22Response Inhibition Training for Individuals With TrichotillomaniaCompletedNCT01638975
23Cognitive Behavioral Treatment of Pediatric TrichotillomaniaCompletedNCT00043563
24Evaluation and Follow-up of Individuals With Obsessive-Compulsive Disorder and Related ConditionsCompletedNCT00004550
25Cortical Excitability in Obsessive-Compulsive and Related DisordersCompletedNCT00029068
26Evaluation of a Brief Surf the Urge InterventionCompletedNCT02771886
27Genetics of Obsessive-Compulsive DisorderCompletedNCT00001548
28Online Response Inhibition Training for TrichotillomaniaRecruitingNCT01984333
29Examining Behavior Therapy for Trichotillomania in Children and AdolescentsRecruitingNCT00917098
30Cognitive Training in Patients With Trichotillomania (Hair-pulling Disorder)RecruitingNCT02794753
31Developing Effective Response Inhibition Training for Symptom Relief in OCD and TrichotillomaniaRecruitingNCT02059980
32Treating Skin Picking With Cognitive-Behavioral Protocol in Individual and Group Format: a Randomized Clinical TrialRecruitingNCT03182478
33Hair Fall in Patients on Low Dose MethotrexateRecruitingNCT02591823
34Glutathione Levels and CompulsivityRecruitingNCT02794389
35Cognitive Behavioral Group Therapy for Trichotillomania (Hair Pulling Disorder)Active, not recruitingNCT02747771
36Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed ProfessionalsActive, not recruitingNCT01075672

Search NIH Clinical Center for Trichotillomania


Cochrane evidence based reviews: trichotillomania

Genetic Tests for Trichotillomania

About this section

Genetic tests related to Trichotillomania:

id Genetic test Affiliating Genes
1 Trichotillomania27

Anatomical Context for Trichotillomania

About this section

MalaCards organs/tissues related to Trichotillomania:

36
Eye, Skin, Brain, Testes

Publications for Trichotillomania

About this section

Articles related to Trichotillomania:

(show top 50)    (show all 542)
idTitleAuthorsYear
1
Trichoscopic clues for diagnosis of alopecia areata and trichotillomania in Asians. (28074524)
2017
2
Preventing, treating, and predicting barbering: A fundamental role for biomarkers of oxidative stress in a mouse model of Trichotillomania. (28426681)
2017
3
Pharmacotherapy of trichotillomania. (28440210)
2017
4
Modified-Release Methylphenidate-Related Trichotillomania in a Boy with Autism Spectrum Disorder. (28394174)
2017
5
Increased Trichotillomania Symptoms in a Child With Fluoxetine Treatment. (28118168)
2017
6
Trichotillomania in Attention-Deficit/Hyperactivity Disorder Under Methylphenidate Treatment. (28492426)
2017
7
Trichotillomania: the impact of treatment history on the outcome of an Internet-based intervention. (28461751)
2017
8
Trichotillomania: a case report with clinical and dermatoscopic differential diagnosis with alopecia areata. (28225970)
2017
9
Trichotillomania and Bipolar Disorder. (28142271)
2017
10
Refining Treatment Approaches in Comorbid Trichotillomania and Bipolar Disorder: Response to Sharma and Baczynski. (28142278)
2017
11
Trichotillomania and its clinical relationship to depression and anxiety. (28429625)
2017
12
Videodermoscopy supports the diagnosis of eyelash trichotillomania. (28426900)
2017
13
Trichotillomania and co-occurring anxiety. (27668531)
2017
14
A double-blind, placebo-controlled study of inositol in trichotillomania. (27824633)
2017
15
Trichotillomania, trichophagia, trichobezoar - summary of three cases. Endoscopic follow up scheme in trichotillomania. (27086334)
2016
16
CURRENT AND FUTURE TREATMENTS OF ALOPECIA AREATA AND TRICHOTILLOMANIA IN CHILDREN. (27484130)
2016
17
Trichotillomania and trichophagia - diagnosis, treatment, prevention. The attempt to establish guidelines of treatment in Poland. (27086333)
2016
18
Treating Trichotillomania (Hair-Pulling Disorder) in a Child. (27701731)
2016
19
Investigation of the Phenomenological and Psychopathological Features of Trichotillomania in an Italian Sample. (26941700)
2016
20
Psychosocial dysfunction associated with skin picking disorder and trichotillomania. (27137963)
2016
21
NEO-FFI personality clusters in trichotillomania. (27016621)
2016
22
Sleep-isolated Trichotillomania (SITTM): A Case Report. (27413587)
2016
23
Trichotillomania Among Young Adults: Prevalence and Comorbidity. (27827514)
2016
24
Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl. (27477178)
2016
25
Trichotillomania. (27581696)
2016
26
N-Acetylcysteine in the treatment of trichotillomania: remarkable results in two patients. (27146087)
2016
27
Affective correlates of trichotillomania across the pulling cycle: Findings from an Italian sample of self-identified hair pullers. (27836242)
2016
28
Parent Coping With Adolescent Trichotillomania. (27457154)
2016
29
Affective regulation in trichotillomania before and after self-help interventions. (26783728)
2016
30
IMPAIRED EXECUTIVE FUNCTIONING IN PEDIATRIC TRICHOTILLOMANIA (HAIR PULLING DISORDER). (26580849)
2016
31
Review of Trichotillomania, Skin Picking and Other Body-Focused Repetitive Behaviors, by Jon E. Grant, Dan J. Stein, Douglas W. Woods, and Nancy J. Keuthen. (26938709)
2016
32
DSM-5 Trichotillomania: Perception of Adults With Trichotillomania After Psychosocial Treatment. (27724833)
2016
33
Trichotillomania as a Manifestation of Dementia. (27840761)
2016
34
Trichotillomania and other 'manias': A lesson in inconsistency, selective concern about stigma and political correctness. (27389065)
2016
35
Report of a Rare Case of Alopecia Areata Coexisting with Trichotillomania. (27127375)
2016
36
Predictors of comorbid obsessive-compulsive disorder and skin-picking disorder in trichotillomania. (27901519)
2016
37
Symptom accommodation, trichotillomania-by-proxy, and interpersonal functioning in trichotillomania (hair-pulling disorder). (26773995)
2016
38
Addressing Self-Control Cognitions in the Treatment of Trichotillomania: A Randomized Controlled Trial Comparing Cognitive Therapy to Behaviour Therapy. (27471331)
2016
39
Factor analysis of the Milwaukee Inventory for Subtypes of Trichotillomania-Adult Version. (27668153)
2016
40
N-acetyl cysteine in the treatment of trichotillomania. (27891708)
2016
41
The Phenomenology of Hair Pulling Urges in Trichotillomania: A Comparative Approach. (26925017)
2016
42
Sex differences in trichotillomania. (27285392)
2016
43
Extensive cicatricial alopecia in a patient with long-term trichotillomania. (26813077)
2016
44
Review of available studies of the neurobiology and pharmacotherapeutic management of trichotillomania. (26966559)
2016
45
Trichobezoar (Rapunzel syndrome) in an adolescent patient with Trichotillomania and Generalized Anxiety Disorder: A case report. (27969077)
2016
46
A 'Hairy' problem: Trichotillomania, trichophagia and trichobezoars. (27439704)
2016
47
Comprehensive Behavioral Treatment of Trichotillomania: A Treatment Development Study. (26643276)
2016
48
Trichotillomania in Celiac Disease. (27920650)
2016
49
Pathologic grooming (acne excoriee, trichotillomania, and nail biting) in 4 generations of a single family. (27051827)
2016
50
Defining treatment response in trichotillomania: a signal detection analysis. (26422605)
2015

Variations for Trichotillomania

About this section

Clinvar genetic disease variations for Trichotillomania:

5
id Gene Variation Type Significance SNP ID Assembly Location
1SLITRK1NM_ 052910.2(SLITRK1): c.1264delC (p.Leu422Phefs)deletionPathogenicrs193302861GRCh37Chr 13, 84454379: 84454379

Expression for genes affiliated with Trichotillomania

About this section
Search GEO for disease gene expression data for Trichotillomania.

Pathways for genes affiliated with Trichotillomania

About this section

GO Terms for genes affiliated with Trichotillomania

About this section

Sources for Trichotillomania

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet